433 related articles for article (PubMed ID: 8247547)
41. Regulation by bcl-2, c-myc, and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation-competent and -defective myeloid leukemic cells.
Lotem J; Sachs L
Cell Growth Differ; 1993 Jan; 4(1):41-7. PubMed ID: 8424905
[TBL] [Abstract][Full Text] [Related]
42. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells.
Chen HW; Huang HC
Br J Pharmacol; 1998 Jul; 124(6):1029-40. PubMed ID: 9720770
[TBL] [Abstract][Full Text] [Related]
43. p53-independent apoptosis associated with c-Myc-mediated block in myeloid cell differentiation.
Amanullah A; Liebermann DA; Hoffman B
Oncogene; 2000 Jun; 19(26):2967-77. PubMed ID: 10871848
[TBL] [Abstract][Full Text] [Related]
44. Apoptosis in Burkitt lymphoma cells is driven by c-myc.
Milner AE; Grand RJ; Waters CM; Gregory CD
Oncogene; 1993 Dec; 8(12):3385-91. PubMed ID: 8247541
[TBL] [Abstract][Full Text] [Related]
45. Transforming growth factor-beta 2 induces apoptosis of murine T cell clones without down-regulating bcl-2 mRNA expression.
Weller M; Constam DB; Malipiero U; Fontana A
Eur J Immunol; 1994 Jun; 24(6):1293-300. PubMed ID: 8206089
[TBL] [Abstract][Full Text] [Related]
46. Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis.
Marin MC; Hsu B; Meyn RE; Donehower LA; el-Naggar AK; McDonnell TJ
Oncogene; 1994 Nov; 9(11):3107-12. PubMed ID: 7936633
[TBL] [Abstract][Full Text] [Related]
47. Apoptosis is induced in BHK cells by the tsBN462/13 mutation in the CCG1/TAFII250 subunit of the TFIID basal transcription factor.
Sekiguchi T; Nakashima T; Hayashida T; Kuraoka A; Hashimoto S; Tsuchida N; Shibata Y; Hunter T; Nishimoto T
Exp Cell Res; 1995 Jun; 218(2):490-8. PubMed ID: 7796884
[TBL] [Abstract][Full Text] [Related]
48. Involvement of BCL-2 in glucocorticoid-induced apoptosis of human pre-B-leukemias.
Alnemri ES; Fernandes TF; Haldar S; Croce CM; Litwack G
Cancer Res; 1992 Jan; 52(2):491-5. PubMed ID: 1728422
[TBL] [Abstract][Full Text] [Related]
49. Properties of incompletely immortalized cell lines generated from a line established from temperature-sensitive SV40 T-antigen gene transgenic mice.
Taher A; Yanai N; Obinata M
Exp Cell Res; 1995 Aug; 219(2):332-8. PubMed ID: 7641784
[TBL] [Abstract][Full Text] [Related]
50. Wild type p53 and c-myc co-operation in generating apoptosis of a rat hepatocellular carcinoma cell line (FAA-HTC1).
Saito Y; Ogawa K
Oncogene; 1995 Sep; 11(6):1013-8. PubMed ID: 7566958
[TBL] [Abstract][Full Text] [Related]
51. Apoptotic cell death induced by c-myc is inhibited by bcl-2.
Bissonnette RP; Echeverri F; Mahboubi A; Green DR
Nature; 1992 Oct; 359(6395):552-4. PubMed ID: 1406975
[TBL] [Abstract][Full Text] [Related]
52. Induction of bax by genotoxic stress in human cells correlates with normal p53 status and apoptosis.
Zhan Q; Fan S; Bae I; Guillouf C; Liebermann DA; O'Connor PM; Fornace AJ
Oncogene; 1994 Dec; 9(12):3743-51. PubMed ID: 7970735
[TBL] [Abstract][Full Text] [Related]
53. Wild-type p53-induced apoptosis in a Burkitt lymphoma cell line is inhibited by interferon gamma.
Sangfelt O; Einhorn S; Björklund AC; Wiman KG; Okan I; Grandér D
Int J Cancer; 1996 Jul; 67(1):106-12. PubMed ID: 8690509
[TBL] [Abstract][Full Text] [Related]
54. The functional basis of c-myc and bcl-2 complementation during multistep lymphomagenesis in vivo.
Marin MC; Hsu B; Stephens LC; Brisbay S; McDonnell TJ
Exp Cell Res; 1995 Apr; 217(2):240-7. PubMed ID: 7698223
[TBL] [Abstract][Full Text] [Related]
55. Differential sensitivity of normal and Ha-ras-transformed C3H mouse embryo fibroblasts to tumor necrosis factor: induction of bcl-2, c-myc, and manganese superoxide dismutase in resistant cells.
Fernandez A; Marin MC; McDonnell T; Ananthaswamy HN
Oncogene; 1994 Jul; 9(7):2009-17. PubMed ID: 8208546
[TBL] [Abstract][Full Text] [Related]
56. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma.
Dole M; Nuñez G; Merchant AK; Maybaum J; Rode CK; Bloch CA; Castle VP
Cancer Res; 1994 Jun; 54(12):3253-9. PubMed ID: 8205548
[TBL] [Abstract][Full Text] [Related]
57. Transformation of follicular lymphoma. Expression of p53 and bcl-2 oncoprotein, apoptosis and cell proliferation.
Symmans WF; Katz RL; Ordoñez NG; Dalton H; Romaguera JE; Cabanillas F
Acta Cytol; 1995; 39(4):673-82. PubMed ID: 7631541
[TBL] [Abstract][Full Text] [Related]
58. Involvement of p53 expression in cAMP-mediated apoptosis in immortalized granulosa cells.
Keren-Tal I; Suh BS; Dantes A; Lindner S; Oren M; Amsterdam A
Exp Cell Res; 1995 May; 218(1):283-95. PubMed ID: 7737366
[TBL] [Abstract][Full Text] [Related]
59. c-myc and p53 gene expression in the differentiation of temperature-sensitive mutants of teratocarcinoma F9 cells.
Kosaka M; Iwai SA; Nishina Y; Sumi T; Nishimune Y
Oncogene; 1992 Dec; 7(12):2455-60. PubMed ID: 1461650
[TBL] [Abstract][Full Text] [Related]
60. Wild-type murine p53 represses transcription from the murine c-myc promoter in a human glial cell line.
Moberg KH; Tyndall WA; Hall DJ
J Cell Biochem; 1992 Jun; 49(2):208-15. PubMed ID: 1400626
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
